1. Home
  2. WD vs TNDM Comparison

WD vs TNDM Comparison

Compare WD & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

N/A

Current Price

$38.15

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

N/A

Current Price

$20.00

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WD
TNDM
Founded
1937
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
WD
TNDM
Price
$38.15
$20.00
Analyst Decision
Buy
Buy
Analyst Count
4
25
Target Price
★ $49.33
$26.90
AVG Volume (30 Days)
501.3K
★ 2.4M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 7.04%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $1,234,306,000.00
$1,014,736,000.00
Revenue This Year
$5.82
$6.14
Revenue Next Year
$8.84
$8.10
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.99
7.93
52 Week Low
$31.40
$12.26
52 Week High
$66.47
$29.65

Technical Indicators

Market Signals
Indicator
WD
TNDM
Relative Strength Index (RSI) 55.12 59.52
Support Level $31.40 $17.61
Resistance Level $52.37 $20.44
Average True Range (ATR) 1.65 1.34
MACD 0.44 0.08
Stochastic Oscillator 56.63 94.80

Price Performance

Historical Comparison
WD
TNDM

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: